2,3-Dibromopropan-1-ol.
D000818:Animals; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000009:adverse effects* / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D004195:Disease Models, Animal; D004781:Environmental Exposure / Q000009:adverse effects* / Q000032:analysis; D005260:Female; D005411:Flame Retardants / Q000009:adverse effects* / Q000032:analysis / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D020005:Propanols / Q000009:adverse effects* / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D051381:Rats
D002273:Carcinogens; D005411:Flame Retardants; D020005:Propanols; C016369:2,3-dibromopropanol